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Vocal cord dysfunction (VCD) is characterised by paradoxical vocal cord adduction during
inspiration or throughout the respiratory cycle, it results in wheeze, stridor, cough and
dyspnoea. Although asthma and VCD can coexist, patients with VCD are frequently
misdiagnosed with refractory asthma. It can severely restrict an individual’s level of
activity and effective therapeutic control can be difficult to achieve. We report the case of
a patient who was treated with all available therapeutic interventions, including
intralaryngeal botulinum toxin injection, but failure resulted in a permanent trachesot-
omy.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Vocal cord dysfunction (VCD) is characterised by paradoxical
vocal cord adduction during inspiration or throughout the
respiratory cycle, it results in wheeze, stridor, cough and
dyspnoea.1 Although asthma and VCD can co-exist, patients
with VCD are frequently misdiagnosed with refractory
asthma.2 In the emergency department, exacerbations
may be incorrectly triaged as acute asthma or acute upper
respiratory tract obstruction, resulting in unnecessary
tracheal intubation or tracheostomy.3
VCD is most prevalent among young women aged 20–40 yr
and is thought to be primarily psychological in causation.1Elsevier Ltd. All rights reserved.
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oo.co.uk (R. Goldstein).Ayres and Gabbott4 have suggested that laryngeal hyper-
responsiveness to stimuli such as cold air and stress may
alter autonomic balance and represent the pathophysiology
of VCD. It can severely restrict an individual’s level of
activity and effective therapeutic control can be difficult to
achieve. We report the case of a patient who was treated
with all available therapeutic interventions, including intra-
laryngeal botulinum toxin injection, but failure resulted in a
permanent trachesotomy.Case
A 38-yr-old gentleman was referred with poorly controlled
adult onset asthma, associated with a raised eosinophil
count. At this time his main symptoms were dry cough,
dyspnoea and gastro-oesophageal reflux. He had a 20 pack
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Figure 1 Adducted true and false cords, 1 week after
botulinum toxin injection.
R. Goldstein et al.858year smoking history with normal alpha I anti-trypsin levels.
Occupational history included employment in the rubber
and printing industry. Despite increasing anti-asthma ther-
apy, hospital admissions were becoming more frequent and
the patient was forced to retire from work.
Pulmonary function testing was poorly reproducible but
more consistent with restrictive rather than obstructive
pulmonary disease but CT scanning of the thorax demon-
strated normal lung fields and normal bronchial airways. At
first bronchoscopy, the vocal cords functioned normally and
saline failed to induce a stridor. Shortly after bronchoscopy,
the patient developed an inspiratory stridor and laryngo-
scopic examination revealed paradoxically adducted vocal
cords. An emergency tracheostomy was performed by the on
call ENT surgeons who made a diagnosis of bilateral vocal
cord paralysis. CT scanning showed normal laryngeal and
tracheal airway.
While the tracheostomy was in situ, the patient did not
have any respiratory related hospital admissions and a
repeat laryngoscopic examination confirmed normal vocal
cord function. The tracheostomy was decannnulated seven
months after insertion, since the site became chronically
infected with methlicillin resistant staphylococcus aureus
and no conservative therapies had been attempted.
Following decannulation, the patient had two acute
hospital admissions with stridor and other exacerbations
lasting up to 1 week which were managed at home. Thus, a
co-ordinated multi-disciplinary treatment programme was
needed.
Firstly, intensive outpatient and inpatient speech therapy
was commenced over a 9-month period, using release and
relaxation techniques allied with stress counselling. This
approach had some success but did not prevent an acute
respiratory admission with stridor, when laryngoscopic
examination confirmed the diagnosis of VCD.
A face mask with inspiratory resistance, which decreases
vocal cord adduction by reducing inspiratory air flow, was
produced for the patient.5 This approach resulted in a 2
month period of good symptom control without any hospital
admissions. However, the success was not maintained and
eventually the stridor became continuous while the patient
remained awake.
Botulinum toxin injection of the true and false vocal cords
was performed, using techniques described in spasmodic
dysphonia with doses of 10 units to both thryoarytenoids and
2.5 units to both false cords.6 Vlahakis et al.7 have reported
mild symptomatic relief following such an approach in VCD.
In our case, the symptoms fully resolved within 48 h but
unfortunately recurred within 1 week of the procedure.
Laryngoscopic examinations during the relapse showed
laryngeal closure caused by false and true cord adduction
(Fig. 1). In view of recurrent relapses, the patient was
discharged with a permanent tracheostomy.
Discussion
This is the first documented British case of VCD, in which all
recommended and available therapies have been system-atically attempted. Unfortunately, despite speech therapy,
stress counselling, an inspiratory resistance mask and
botulinum toxin injections, tracheostomy reinsertion could
not be prevented.
The underlying aetiology in this case includes psycholo-
gical stress, gastro-intestinal reflux and asthma; these were
all addressed in the therapeutic programme outlined.
Treatment of VCD challenges respiratory physicians and
requires a co-ordinated multi-disciplinary treatment pro-
gramme to optimise the chance of success.References
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